US20050158450A1 - Method for roll coating multiple stents - Google Patents

Method for roll coating multiple stents Download PDF

Info

Publication number
US20050158450A1
US20050158450A1 US11/073,848 US7384805A US2005158450A1 US 20050158450 A1 US20050158450 A1 US 20050158450A1 US 7384805 A US7384805 A US 7384805A US 2005158450 A1 US2005158450 A1 US 2005158450A1
Authority
US
United States
Prior art keywords
stents
coating
stent
holders
conveyer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/073,848
Inventor
Maria Palasis
Wendy Naimark
Tim Mickley
Toby Freyman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Scimed Inc
Original Assignee
Boston Scientific Scimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Scientific Scimed Inc filed Critical Boston Scientific Scimed Inc
Priority to US11/073,848 priority Critical patent/US20050158450A1/en
Publication of US20050158450A1 publication Critical patent/US20050158450A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00Processes for applying liquids or other fluent materials
    • B05D1/02Processes for applying liquids or other fluent materials performed by spraying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08Materials for coatings
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05BSPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B13/00Machines or plants for applying liquids or other fluent materials to surfaces of objects or other work by spraying, not covered by groups B05B1/00 - B05B11/00
    • B05B13/02Means for supporting work; Arrangement or mounting of spray heads; Adaptation or arrangement of means for feeding work
    • B05B13/0221Means for supporting work; Arrangement or mounting of spray heads; Adaptation or arrangement of means for feeding work characterised by the means for moving or conveying the objects or other work, e.g. conveyor belts
    • B05B13/0235Means for supporting work; Arrangement or mounting of spray heads; Adaptation or arrangement of means for feeding work characterised by the means for moving or conveying the objects or other work, e.g. conveyor belts the movement of the objects being a combination of rotation and linear displacement
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05CAPPARATUS FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05C3/00Apparatus in which the work is brought into contact with a bulk quantity of liquid or other fluent material
    • B05C3/02Apparatus in which the work is brought into contact with a bulk quantity of liquid or other fluent material the work being immersed in the liquid or other fluent material
    • B05C3/09Apparatus in which the work is brought into contact with a bulk quantity of liquid or other fluent material the work being immersed in the liquid or other fluent material for treating separate articles
    • B05C3/10Apparatus in which the work is brought into contact with a bulk quantity of liquid or other fluent material the work being immersed in the liquid or other fluent material for treating separate articles the articles being moved through the liquid or other fluent material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00Processes for applying liquids or other fluent materials
    • B05D1/002Processes for applying liquids or other fluent materials the substrate being rotated
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D2258/00Small objects (e.g. screws)

Definitions

  • the present invention generally regards the holding of stents during manufacture to enable the application of therapeutic and/or protective coatings. More specifically, the present invention pertains to a method for high-throughput, efficient and uniform coating of stents, wherein the stents placed on rotating fixtures on a conveyer, and the conveyer passes the rotating stents through a coating spray or immersion bath to apply a coating to the stents.
  • Medical implants are used for innumerable medical purposes, including the reinforcement of recently re-enlarged lumens, the replacement of ruptured vessels, and the treatment of disease such as vascular disease by local pharmacotherapy, i.e., delivering therapeutic drug doses to target tissues while minimizing systemic side effects.
  • local pharmacotherapy i.e., delivering therapeutic drug doses to target tissues while minimizing systemic side effects.
  • Such localized delivery of therapeutic agents has been proposed or achieved using medical implants which both support a lumen within a patient's body and place appropriate coatings containing absorbable therapeutic agents at the implant location.
  • Expandable stents are tube-like medical devices, typically made from stainless steel, Tantalum, Platinum or Nitinol alloys, designed to be placed within the inner walls of a lumen within the body of a patient. These stents are typically maneuvered to a desired location within a lumen of the patient's body and then expanded to provide internal support for the lumen.
  • the stents may be self-expanding or, alternatively, may require external forces to expand them, such as by inflating a balloon attached to the distal end of the stent delivery catheter.
  • stents Because of the direct contact of the stent with the inner walls of the lumen, stents have been coated with various compounds and therapeutic agents to enhance their effectiveness. These coatings may, among other things, be designed to facilitate the acceptance of the stent into its applied surroundings. Such coatings may also be designed to facilitate the delivery of one of the foregoing therapeutic agents to the target site for treating, preventing, or otherwise affecting the course of a disease or tissue or organ dysfunction.
  • the stent has been coated, care must be taken during its manufacture and delivery within the patient to ensure the coating is evenly applied and firmly adherent to the stent, and further that the coating is not damaged or completely removed from the implant during the deployment process.
  • the amount of coating is depleted the implant's effectiveness may be compromised and additional risks may be inured into the procedure.
  • the coating of the implant includes a therapeutic, if some of the coating were removed during deployment, the therapeutic may no longer be able to be administered to the target site in a uniform and homogenous manner. Thus, some areas of the target site may receive high quantities of therapeutic while others may receive low quantities of therapeutic.
  • the therapeutic if the therapeutic is ripped from the implant it can reduce or slow down the blood flowing past it, thereby, increasing the threat of thrombosis or, if it becomes dislodged, the risk of embolisms.
  • the removal and reinsertion of the stent through a second medical procedure may be required where the coatings have been damaged or are defective.
  • the mechanical process of applying a coating onto a stent may be accomplished in a variety of ways, including, for example, the spraying of the coating substance onto the stent and so-called spin-dipping, i.e., dipping a spinning stent into a coating solution to achieve the desired coating.
  • spin-dipping i.e., dipping a spinning stent into a coating solution to achieve the desired coating.
  • common to these processes is the need to apply the coating in a uniform manner to ensure an intact, robust coating of the desired thickness is formed on the stent.
  • a further disadvantage of these prior stent coating processes is that, because the stents are wire mesh structures with substantial void area between the mesh wires, the utilization of the stent coating material sprayed toward the stents is very low. For example, in some cases the amount of stent coating sprayed toward the stent which actually adheres to the stent mesh is less than five percent.
  • the present invention is directed to a method for overcoming the foregoing disadvantages. Specifically, in a first step of a first embodiment of the method, stents are loaded with high speed stent handling equipment onto rotating pins that are mounted to an endless conveyer belt. In a second step, while the stents are rolling about their longitudinal axes atop the rotating pins, stent coating material is applied as the endless belt advances the stents through a stent coater containing a coating sprayer. As the stents are returned toward the stent loading area by the endless belt, they receive additional coating material from the coating sprayer as they pass a second time through the coating spray downstream of the initial coating location. The coated stents are then removed from their holders before the endless belt returns the stent holders to the stent loading area to receive new uncoated stents.
  • a number of alternative embodiments for performance of the method of the present invention are envisioned.
  • there may be a number of alternative embodiments for performing the stent placement step such as providing stents pre-mounted on stent holders with rotating pins equipping with corresponding stent holder receivers to facilitate stent handling by automated stent placement equipment.
  • the coating may be applied from a sprayer aligned with the major axis of the endless belt such that the rolling stents have a longer exposure to the coating spray.
  • the sprayer may also apply the coating while the spray head is rotating about the line of rolling stents.
  • the coating application step may be performed by drawing the rolling stents through a coating bath.
  • Other embodiments extend the stent coating step to include the endless belt reversing direction several times to cause the rolling stents to pass several times through the downstream portions of the coating spray to improve coating material utilization, and the inclusion of additional stent processing steps between the coating application step and the coated stent unloading step, such as accelerating the drying of the stent coating by advancing the coated stents through an infrared coating dryer.
  • the result of the various foregoing embodiments of the method of the present invention is high volume, efficient and lower-cost production of stents with a highly uniform coating on their exterior and, in desired, interior surfaces.
  • FIG. 1 is a schematic overhead view of a stent coating process in accordance with an embodiment of the method the present invention.
  • FIG. 2 is a side view showing a stent and the upper portion of a rotating pin on which the stent is placed in accordance with the method of the present invention.
  • FIG. 3 is a side illustration of stent-bearing rotating pins mounted on a conveyer belt in accordance with the method of the present invention.
  • FIG. 4 is an overhead view of the stent-bearing rotating pins and conveyer belt shown in FIG. 3 in accordance with the method of the present invention.
  • FIG. 5 is a schematic overhead view of the stent-bearing rotating pins and conveyer belt shown in FIG. 3 illustrating an alternative approach for the step of applying the stent coating in accordance with the method of the present invention.
  • FIG. 6 are schematic side views of alternative stent holders and rotating pin mounts for engaging and holding stent holders for performing the step of placing the stents on the conveyer in accordance with the method of the present invention.
  • FIG. 7 is a schematic side view of the stent-bearing rotating pins and conveyer belt shown in FIG. 3 showing an alternative approach to the step of applying the stent coating by immersing the stents into a coating bath in accordance with the method of the present invention.
  • the present invention is directed to a method for overcoming the foregoing disadvantages by applying a stent coating to stents that are being rolled about their longitudinal axis, where the stents are loaded onto rotating holders affixed to a conveyer, and the conveyer carries the rotating stents and holders through a coating applicator one or more times.
  • a conveyer in the form of an endless belt 1 is arranged around a first pulley 2 at a first end 3 of the belt and a second pulley 4 at a second, opposite end 5 of the belt.
  • Endless belt 1 may be advanced by rotating either pulley 2 or pulley 4 .
  • Backing plates 6 are provided in the region between pulleys 2 and 4 .
  • the backing plates which can be located adjacent to either the inner or outer face of the belt, are arranged to contact outer peripheral edges of rotating pins 7 mounted on endless belt 1 (details of rotating pins 7 and their mounting are discussed further, below).
  • stents 8 are placed with automated stent placement equipment (not illustrated) onto rotating pins 7 as endless belt 1 is advanced.
  • the stents are loaded onto the rotating pins near the first end 3 of the endless belt, and advance toward second end 5 as endless belt 1 advances.
  • the freshly loaded, uncoated stents are on endless belt 1 on the lower side of the illustration, moving from first end 3 toward second end 5 .
  • a stent coater 9 is positioned such that it dispenses a stent coating spray toward endless belt 1 when activated.
  • stent coater 9 includes a stent coating sprayer 10 located near second end 5 which sprays the coating material generally perpendicularly across endless belt 1 .
  • the stent coater may further include a housing (not illustrated) to contain and potentially reclaim coating overspray.
  • endless belt 1 is advanced to cause stents 8 to roll about their longitudinal axes as their respective pins 7 rotate (due to the pins' frictional engagement with backing plate 6 ).
  • the rolling stents 8 are simultaneously carried along the path of endless belt 1 into and out of the stent coater.
  • the step of applying the stent coating to the stents is performed by causing coating sprayer 10 to dispense the stent coating onto stents 8 as they pass through the stent coater.
  • endless belt 1 reverses direction at pulley 4
  • stent coating spray that passes by or through the stents moving toward second end 5 can be utilized to apply additional coating material to the stents as they pass from second end 5 back toward first end 3 , thereby substantially improving the efficiency of the coating process.
  • the coated stents 8 approach first end 3 , they are removed from their respective rotating pins 7 by automated stent removal equipment (not illustrated), prior to the rotating pins' return to the stent loading area for loading of new uncoated stents.
  • FIG. 2 illustrates a schematic view of the upper portion of a rotating pin 7 and its relationship to stent 8 .
  • stent 8 When placed onto rotating pin 7 , stent 8 is oriented with its longitudinal axis generally in line with the longitudinal axis of a rotating pin 7 .
  • Rotating pin 7 is sized such that when stent 8 is placed over the top of pin 7 , the stent is supported by pin 7 in a manner which ensures that stent 8 rotates with pin 7 when the pin is rotated around its longitudinal axis.
  • rotating pin 7 has a radial extension or shelf 11 upon which stent 8 rests when placed over the top of pin 7 .
  • rotating pin 7 may have a tapered shape, such that the inner diameter of stent 8 rests directly upon the tapered sides of pin 7 .
  • Rotating pin 7 is preferably configured such that its protrusion into the interior annular region of stent 8 , while sufficient to ensure stent 8 is retained on the pin during its transit through stent coating applicator 9 , is minimized in order to minimize the extent to which pin 7 interferes with the application of the coating spray to the inner surface of stent 8 .
  • FIG. 3 shows the general arrangement of rotating pins 7 and stents 8 on endless belt 1 in the first embodiment.
  • stents 8 rest on the tops of rotating pins 7 , which are in turn rotably held on belt 1 .
  • Any of a variety of conveyer arrangements well known in the art may be used to rotably hold pins 7 .
  • the pins are held by belt links 12 of endless belt 1 .
  • the belt links 12 may be arranged any suitable manner that permits the pins 7 to rotate about their longitudinal axes as the belt advances, such as with interlocking fingers or hooks 13 on the ends of the links which cooperate with the pins 7 and an adjacent link to effectively use rotating pins 7 as hinge pins in the endless belt, as illustrated in FIG. 3 a .
  • endless belt 1 may be an endless rubber belt to which are mounted U-shaped brackets which loosely capture rotating pins 7 between the belt and the brackets, as illustrated in FIG. 3 b.
  • a flange 14 is provided in this embodiment on each rotating pin 7 .
  • flange 14 is of sufficient radius that its outer periphery is in rolling contact with backing plates 6 as endless belt 1 advances, thereby causing pins 7 and their respective, stents 8 to roll about their longitudinal axes as belt 1 advances.
  • Flange 14 may be provided above, below, or in a gap through, endless belt 1 , as desired to provide positive engagement of flanges 14 against backing plates 6 .
  • rotating pins 7 may be rotated by means that are independent of the means that advance endless belt, for example, by a separate electric motor.
  • the diameter of flange 14 and the speed of advance of endless belt 1 are adjusted as necessary to ensure an optimal stent coating is obtained.
  • An endless belt advance speed of 0.1-10 cm per second and a stent rotation rate of 10-100 degrees per second may be used to obtain satisfactory coating of stents with the foregoing roll coating method.
  • coating sprayer 10 may be elevated above endless belt 1 and aligned to dispense the coating spray downward at an angle toward the rolling stents 8 .
  • coating sprayer 10 could also be located above endless belt 1 and aligned with the belt such that it sprays in the direction of stent travel and thus has an extended opportunity to apply the coating to the stents.
  • the coating sprayer may be provided on means such as a rotating arm that permits the sprayer to rotate around the rolling stents as they are advanced on the conveyer. Performing the coating application step in this embodiment provides further assurance a uniform coating will be obtained at high coated stent production levels.
  • An additional embodiment of the present method includes multiple direction reversals of endless belt 1 downstream of coating sprayer 10 such that stents 8 re-enter the spray dispensed from sprayer 10 several times before belt 1 returns to a stent removal station.
  • this embodiment provides for enhanced coating efficiency as each pass of stents 8 through the downstream portions of the coating spray further improves the utilization of the sprayed coating and thereby improves coating efficiency.
  • a further advantage of the foregoing method is that after the step of applying the coating to the rolling stents, there may be provided additional steps which enhance high volume coated stent production.
  • An exemplary further embodiment of the present method thus may include the step of passing the stents through a coating dryer (such as an infrared heater) following the application of the coating, wherein the rolling stents present all their coated surfaces to the dryer for even, accelerated drying prior to removal from their respective rotating pins 7 .
  • a coating dryer such as an infrared heater
  • the conveyer and/or the stent holder may be heated to accelerate coating drying rates before the stents are removed from the conveyer.
  • the stents are placed on rotating pins with upper portions that are shaped to directly receive the stents.
  • the stents may be supplied for loading onto endless belt 1 already mounted on individual stent holders, where the upper portion of rotating pins 7 is adapted to grasp one end of the holder.
  • FIG. 6 shows three example stent holder and cooperating rotating pin arrangements which are amenable to high-volume automated stent placement and removal operations.
  • stent 8 is mounted on stent holder 15 .
  • FIG. 6 b illustrates another stent holder 15 formed from a nitinol wire that holds stent 8 by spring force at contact points on the stent's inner surface, where receiving portion 16 is a spring-loaded clamp that grasps one end of stent holder 15 .
  • FIG. 6 b illustrates another stent holder 15 formed from a nitinol wire that holds stent 8 by spring force at contact points on the stent's inner surface, where receiving portion 16 is a spring-loaded clamp that grasps one end of stent holder 15 .
  • FIG. 6c shows a further exemplary embodiment, wherein stent holder 15 is a wire frame with triangular ends 18 , stent 8 is held under a light compressive force between the ends 18 , and extension 17 from stent holder 15 is a wire that is placed into the receiving portion 16 of rotating pin 7 (in this case, a hole drilled into the top of pin 7 ).
  • FIG. 6 d shows another exemplary embodiment, wherein stent holder 15 is an inflatable balloon that lightly presses against the inner surface of stent 8 and is held, in this embodiment, in a receiving portion 16 that grasps one end of the stent holder balloon 15 .
  • the foregoing alternative approaches to the stent placement step which positively constrain stents 8 to remain mounted on rotating pins 7 , facilitate a further embodiment of the present method.
  • the coating may be applied by advancing endless belt 1 through a stent coating bath 19 , as schematically illustrated in FIG. 7 . It should be apparent to those of skill in the art that while positive control of rolling stents 8 on the top of rotating pins 7 is not a necessary prerequisite to use of a coating bath, use of the foregoing alternative stent holders coupled to the rotating pins enhances the control of the stents as they pass through coating bath 19 .
  • endless belt 1 is shown in FIG. 7 as being turned to a horizontal position to pass through coating bath 19 , no orientation limitations are intended to be implied by the foregoing description, as a number of modifications and equivalent alternative arrangements are possible.
  • endless belt 1 may be arranged above the coating bath and located such that stents 8 are held and rotated about their longitudinal axes below belt 1 , such that only the stents and their holders pass through the coating bath during the coating application step.
  • therapeutic agent includes one or more “therapeutic agents” or “drugs.”
  • therapeutic agents and “drugs” are used interchangeably herein and include pharmaceutically active compounds, nucleic acids with and without carrier vectors such as lipids, compacting agents (such as histones), virus (such as adenovirus, andenoassociated virus, retrovirus, lentivirus and ⁇ -virus), polymers, hyaluronic acid, proteins, cells and the like, with or without targeting sequences.
  • therapeutic agents used in conjunction with the present invention include, for example, pharmaceutically active compounds, proteins, cells, oligonucleotides, ribozymes, anti-sense oligonucleotides, DNA compacting agents, gene/vector systems (i.e., any vehicle that allows for the uptake and expression of nucleic acids), nucleic acids (including, for example, recombinant nucleic acids; naked DNA, cDNA, RNA; genomic DNA, cDNA or RNA in a non-infectious vector or in a viral vector and which further may have attached peptide targeting sequences; antisense nucleic acid (RNA or DNA); and DNA chimeras which include gene sequences and encoding for ferry proteins such as membrane translocating sequences (“MTS”) and herpes simplex virus-1 (“VP22”)), and viral, liposomes and cationic and anionic polymers and neutral polymers that are selected from a number of types depending on the desired application.
  • gene/vector systems i.e., any vehicle
  • Non-limiting examples of virus vectors or vectors derived from viral sources include adenoviral vectors, herpes simplex vectors, papilloma vectors, adeno-associated vectors, retroviral vectors, and the like.
  • Non-limiting examples of biologically active solutes include anti-thrombogenic agents such as heparin, heparin derivatives, urokinase, and PPACK (dextrophenylalanine proline arginine chloromethylketone); antioxidants such as probucol and retinoic acid; angiogenic and anti-angiogenic agents and factors; agents blocking smooth muscle cell proliferation such as rapamycin, angiopeptin, and monoclonal antibodies capable of blocking smooth muscle cell proliferation; anti-inflammatory agents such as dexamethasone, prednisolone, corticosterone, budesonide, estrogen, sulfasalazine, acetyl salicylic acid, and mesalamine; calcium entry blockers
  • Polynucleotide sequences useful in practice of the invention include DNA or RNA sequences having a therapeutic effect after being taken up by a cell.
  • therapeutic polynucleotides include anti-sense DNA and RNA; DNA coding for an anti-sense RNA; or DNA coding for tRNA or rRNA to replace defective or deficient endogenous molecules or interfering RNA sequences.
  • the polynucleotides can also code for therapeutic proteins or polypeptides.
  • a polypeptide is understood to be any translation product of a polynucleotide regardless of size, and whether glycosylated or not.
  • Therapeutic proteins and polypeptides include as a primary example, those proteins or polypeptides that can compensate for defective or deficient species in an animal, or those that act through toxic effects to limit or remove harmful cells from the body.
  • the polypeptides or proteins that can be injected, or whose DNA can be incorporated include without limitation, angiogenic factors and other molecules competent to induce angiogenesis, including acidic and basic fibroblast growth factors, vascular endothelial growth factor, hif-1, epidermal growth factor, transforming growth factor ⁇ and ⁇ , platelet-derived endothelial growth factor, platelet-derived growth factor, tumor necrosis factor ⁇ , hepatocyte growth factor and insulin like growth factor; growth factors; cell cycle inhibitors including CDK inhibitors; anti-restenosis agents, including p15, p16, p18, p19, p21, p27, p53, p57, Rb, nFkB and E2F decoys, thymidine kina
  • MCP-1 monocyte chemoattractant protein
  • BMP's the family of bone morphogenic proteins
  • the known proteins include BMP-2, BMP-3, BMP-4, BMP-5, BMP-6 (Vgr-1), BMP-7 (OP-1), BMP-8, BMP-9, BMP-10, BMP-11, BMP-12, BMP-13, BMP-14, BMP-15, and BMP-16.
  • BMP's are any of BMP-2, BMP-3, BMP-4, BMP-5, BMP-6 and BMP-7.
  • dimeric proteins can be provided as homodimers, heterodimers, or combinations thereof, alone or together with other molecules.
  • molecules capable of inducing an upstream or downstream effect of a BMP can be provided.
  • Such molecules include any of the “hedgehog” proteins, or the DNA's encoding them.

Abstract

An improved method and apparatus for high-volume production of coated stents with highly uniform stent coatings using a roll coating technique is provided. In a first embodiment, uncoated stents are placed onto rotating stent holders with automated stent handling equipment. The holders are mounted on an endless conveyer belt which advances the stents toward a stent coater. As the stents advance through the coater, the holders rotate, thereby rolling the stents about their longitudinal axes as coating material is sprayed toward them, ensuring the stents are uniformly coated on their exterior and interior surfaces. After the conveyer turns to carry the coated stents back toward the loading area, the rotating stents pass again through the coating spray, downstream of the initial coating location, thereby increasing the efficient utilization of the coating material. The conveyer then advances the coated stents to an unloading area for removal before the holders return to the stent loading area to receive new stents.

Description

    FIELD OF THE INVENTION
  • The present invention generally regards the holding of stents during manufacture to enable the application of therapeutic and/or protective coatings. More specifically, the present invention pertains to a method for high-throughput, efficient and uniform coating of stents, wherein the stents placed on rotating fixtures on a conveyer, and the conveyer passes the rotating stents through a coating spray or immersion bath to apply a coating to the stents.
  • BACKGROUND
  • Medical implants are used for innumerable medical purposes, including the reinforcement of recently re-enlarged lumens, the replacement of ruptured vessels, and the treatment of disease such as vascular disease by local pharmacotherapy, i.e., delivering therapeutic drug doses to target tissues while minimizing systemic side effects. Such localized delivery of therapeutic agents has been proposed or achieved using medical implants which both support a lumen within a patient's body and place appropriate coatings containing absorbable therapeutic agents at the implant location.
  • The delivery of expandable stents is a specific example of a medical procedure that involves the deployment of coated implants. Expandable stents are tube-like medical devices, typically made from stainless steel, Tantalum, Platinum or Nitinol alloys, designed to be placed within the inner walls of a lumen within the body of a patient. These stents are typically maneuvered to a desired location within a lumen of the patient's body and then expanded to provide internal support for the lumen. The stents may be self-expanding or, alternatively, may require external forces to expand them, such as by inflating a balloon attached to the distal end of the stent delivery catheter.
  • Because of the direct contact of the stent with the inner walls of the lumen, stents have been coated with various compounds and therapeutic agents to enhance their effectiveness. These coatings may, among other things, be designed to facilitate the acceptance of the stent into its applied surroundings. Such coatings may also be designed to facilitate the delivery of one of the foregoing therapeutic agents to the target site for treating, preventing, or otherwise affecting the course of a disease or tissue or organ dysfunction.
  • Where the stent has been coated, care must be taken during its manufacture and delivery within the patient to ensure the coating is evenly applied and firmly adherent to the stent, and further that the coating is not damaged or completely removed from the implant during the deployment process. When the amount of coating is depleted the implant's effectiveness may be compromised and additional risks may be inured into the procedure. For example, when the coating of the implant includes a therapeutic, if some of the coating were removed during deployment, the therapeutic may no longer be able to be administered to the target site in a uniform and homogenous manner. Thus, some areas of the target site may receive high quantities of therapeutic while others may receive low quantities of therapeutic. Similarly, if the therapeutic is ripped from the implant it can reduce or slow down the blood flowing past it, thereby, increasing the threat of thrombosis or, if it becomes dislodged, the risk of embolisms. In certain circumstances, the removal and reinsertion of the stent through a second medical procedure may be required where the coatings have been damaged or are defective.
  • The mechanical process of applying a coating onto a stent may be accomplished in a variety of ways, including, for example, the spraying of the coating substance onto the stent and so-called spin-dipping, i.e., dipping a spinning stent into a coating solution to achieve the desired coating. Common to these processes is the need to apply the coating in a uniform manner to ensure an intact, robust coating of the desired thickness is formed on the stent. In order to achieve the desired uniform and complete coating, it has been common for the stents to be handled individually, with each stent separately loaded onto a stent holder and the coating applied to the stent before the next stent is coated. This individual handling typically has resulted in low production rates of coated stents. A further disadvantage of these prior stent coating processes is that, because the stents are wire mesh structures with substantial void area between the mesh wires, the utilization of the stent coating material sprayed toward the stents is very low. For example, in some cases the amount of stent coating sprayed toward the stent which actually adheres to the stent mesh is less than five percent.
  • Thus, there is a need for a method for coating stents which efficiently applies the stent coating material in a manner that results in a high quality, uniform coating on the stents at high coated stent production rates.
  • SUMMARY OF THE INVENTION
  • The present invention is directed to a method for overcoming the foregoing disadvantages. Specifically, in a first step of a first embodiment of the method, stents are loaded with high speed stent handling equipment onto rotating pins that are mounted to an endless conveyer belt. In a second step, while the stents are rolling about their longitudinal axes atop the rotating pins, stent coating material is applied as the endless belt advances the stents through a stent coater containing a coating sprayer. As the stents are returned toward the stent loading area by the endless belt, they receive additional coating material from the coating sprayer as they pass a second time through the coating spray downstream of the initial coating location. The coated stents are then removed from their holders before the endless belt returns the stent holders to the stent loading area to receive new uncoated stents.
  • A number of alternative embodiments for performance of the method of the present invention are envisioned. For example, there may be a number of alternative embodiments for performing the stent placement step, such as providing stents pre-mounted on stent holders with rotating pins equipping with corresponding stent holder receivers to facilitate stent handling by automated stent placement equipment. Similarly, in the step of applying the coating material, rather than spraying the coating material perpendicularly across the endless belt, the coating may be applied from a sprayer aligned with the major axis of the endless belt such that the rolling stents have a longer exposure to the coating spray. The sprayer may also apply the coating while the spray head is rotating about the line of rolling stents. In a further embodiment, the coating application step may be performed by drawing the rolling stents through a coating bath. Other embodiments extend the stent coating step to include the endless belt reversing direction several times to cause the rolling stents to pass several times through the downstream portions of the coating spray to improve coating material utilization, and the inclusion of additional stent processing steps between the coating application step and the coated stent unloading step, such as accelerating the drying of the stent coating by advancing the coated stents through an infrared coating dryer.
  • The result of the various foregoing embodiments of the method of the present invention is high volume, efficient and lower-cost production of stents with a highly uniform coating on their exterior and, in desired, interior surfaces.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a schematic overhead view of a stent coating process in accordance with an embodiment of the method the present invention.
  • FIG. 2 is a side view showing a stent and the upper portion of a rotating pin on which the stent is placed in accordance with the method of the present invention.
  • FIG. 3 is a side illustration of stent-bearing rotating pins mounted on a conveyer belt in accordance with the method of the present invention.
  • FIG. 4 is an overhead view of the stent-bearing rotating pins and conveyer belt shown in FIG. 3 in accordance with the method of the present invention.
  • FIG. 5 is a schematic overhead view of the stent-bearing rotating pins and conveyer belt shown in FIG. 3 illustrating an alternative approach for the step of applying the stent coating in accordance with the method of the present invention.
  • FIG. 6 are schematic side views of alternative stent holders and rotating pin mounts for engaging and holding stent holders for performing the step of placing the stents on the conveyer in accordance with the method of the present invention.
  • FIG. 7 is a schematic side view of the stent-bearing rotating pins and conveyer belt shown in FIG. 3 showing an alternative approach to the step of applying the stent coating by immersing the stents into a coating bath in accordance with the method of the present invention.
  • DETAILED DESCRIPTION
  • The present invention is directed to a method for overcoming the foregoing disadvantages by applying a stent coating to stents that are being rolled about their longitudinal axis, where the stents are loaded onto rotating holders affixed to a conveyer, and the conveyer carries the rotating stents and holders through a coating applicator one or more times.
  • The method of the present invention in a first embodiment is as follows. In this first embodiment, a conveyer in the form of an endless belt 1 is arranged around a first pulley 2 at a first end 3 of the belt and a second pulley 4 at a second, opposite end 5 of the belt. Endless belt 1 may be advanced by rotating either pulley 2 or pulley 4. Backing plates 6 are provided in the region between pulleys 2 and 4. The backing plates, which can be located adjacent to either the inner or outer face of the belt, are arranged to contact outer peripheral edges of rotating pins 7 mounted on endless belt 1 (details of rotating pins 7 and their mounting are discussed further, below). When endless belt 1 is advanced, the friction between the outer peripheral portions of rotating pins 7 and backing plates 6 causes the pins to rotate.
  • As a first step of the method in this embodiment, stents 8 are placed with automated stent placement equipment (not illustrated) onto rotating pins 7 as endless belt 1 is advanced. In this embodiment, the stents are loaded onto the rotating pins near the first end 3 of the endless belt, and advance toward second end 5 as endless belt 1 advances. In FIG. 1, the freshly loaded, uncoated stents are on endless belt 1 on the lower side of the illustration, moving from first end 3 toward second end 5. At a location along endless belt 1 separate from the stent loading location, a stent coater 9 is positioned such that it dispenses a stent coating spray toward endless belt 1 when activated. In this embodiment, stent coater 9 includes a stent coating sprayer 10 located near second end 5 which sprays the coating material generally perpendicularly across endless belt 1. The stent coater may further include a housing (not illustrated) to contain and potentially reclaim coating overspray.
  • In the second step of the method in this first embodiment, endless belt 1 is advanced to cause stents 8 to roll about their longitudinal axes as their respective pins 7 rotate (due to the pins' frictional engagement with backing plate 6). As endless belt 1 advances, the rolling stents 8 are simultaneously carried along the path of endless belt 1 into and out of the stent coater. The step of applying the stent coating to the stents is performed by causing coating sprayer 10 to dispense the stent coating onto stents 8 as they pass through the stent coater. Further, because endless belt 1 reverses direction at pulley 4, stent coating spray that passes by or through the stents moving toward second end 5 can be utilized to apply additional coating material to the stents as they pass from second end 5 back toward first end 3, thereby substantially improving the efficiency of the coating process. Finally, as the coated stents 8 approach first end 3, they are removed from their respective rotating pins 7 by automated stent removal equipment (not illustrated), prior to the rotating pins' return to the stent loading area for loading of new uncoated stents.
  • The rotating pins 7 in this embodiment, and their relationship to endless belt 1, backing plates 6 and stents 8, are now further described. FIG. 2 illustrates a schematic view of the upper portion of a rotating pin 7 and its relationship to stent 8. When placed onto rotating pin 7, stent 8 is oriented with its longitudinal axis generally in line with the longitudinal axis of a rotating pin 7. Rotating pin 7 is sized such that when stent 8 is placed over the top of pin 7, the stent is supported by pin 7 in a manner which ensures that stent 8 rotates with pin 7 when the pin is rotated around its longitudinal axis. In this embodiment, rotating pin 7 has a radial extension or shelf 11 upon which stent 8 rests when placed over the top of pin 7. Alternatively, rotating pin 7 may have a tapered shape, such that the inner diameter of stent 8 rests directly upon the tapered sides of pin 7. Rotating pin 7 is preferably configured such that its protrusion into the interior annular region of stent 8, while sufficient to ensure stent 8 is retained on the pin during its transit through stent coating applicator 9, is minimized in order to minimize the extent to which pin 7 interferes with the application of the coating spray to the inner surface of stent 8.
  • FIG. 3 shows the general arrangement of rotating pins 7 and stents 8 on endless belt 1 in the first embodiment. In both FIG. 3 a and FIG. 3 b, stents 8 rest on the tops of rotating pins 7, which are in turn rotably held on belt 1. Any of a variety of conveyer arrangements well known in the art may be used to rotably hold pins 7. In this embodiment, the pins are held by belt links 12 of endless belt 1. The belt links 12 may be arranged any suitable manner that permits the pins 7 to rotate about their longitudinal axes as the belt advances, such as with interlocking fingers or hooks 13 on the ends of the links which cooperate with the pins 7 and an adjacent link to effectively use rotating pins 7 as hinge pins in the endless belt, as illustrated in FIG. 3 a. Alternatively, endless belt 1 may be an endless rubber belt to which are mounted U-shaped brackets which loosely capture rotating pins 7 between the belt and the brackets, as illustrated in FIG. 3 b.
  • In order to provide for the rotation of rotating pins 7 as endless belt 1 advances, a flange 14 is provided in this embodiment on each rotating pin 7. As shown in the overhead view in FIG. 4, flange 14 is of sufficient radius that its outer periphery is in rolling contact with backing plates 6 as endless belt 1 advances, thereby causing pins 7 and their respective, stents 8 to roll about their longitudinal axes as belt 1 advances. Flange 14 may be provided above, below, or in a gap through, endless belt 1, as desired to provide positive engagement of flanges 14 against backing plates 6. As those of skill in the art will readily recognize, a variety of alternative means other than backing plates 6 may be provided to cause rotating pins 7 to roll stents 8, such as gear-drive of the rotating pins, so as long as the desired rotation of stents 8 is obtained. Alternatively, rotating pins 7 may be rotated by means that are independent of the means that advance endless belt, for example, by a separate electric motor.
  • The diameter of flange 14 and the speed of advance of endless belt 1 are adjusted as necessary to ensure an optimal stent coating is obtained. This requires stents 8 to be rotated at a rate that is slow enough to ensure effective coverage of outer and inner portions of stent 8 by sprayer 10 as the stents traverse through the coating spray, but fast enough to ensure that the stents make at least one complete revolution while stent 8 is within the spray pattern from sprayer 10. An endless belt advance speed of 0.1-10 cm per second and a stent rotation rate of 10-100 degrees per second may be used to obtain satisfactory coating of stents with the foregoing roll coating method.
  • In addition to executing the step of applying the coating to the stents 8 using a spray applicator aligned perpendicular to the direction of advance of endless belt 1, a number of alternative spray configurations can be envisioned. For example, in order to minimize the interference of rotating pins 7 with the application of the coating to the inner surface of stents 8, coating sprayer 10 may be elevated above endless belt 1 and aligned to dispense the coating spray downward at an angle toward the rolling stents 8. As shown in FIG. 5, coating sprayer 10 could also be located above endless belt 1 and aligned with the belt such that it sprays in the direction of stent travel and thus has an extended opportunity to apply the coating to the stents. In a further alternative sprayer embodiment, the coating sprayer may be provided on means such as a rotating arm that permits the sprayer to rotate around the rolling stents as they are advanced on the conveyer. Performing the coating application step in this embodiment provides further assurance a uniform coating will be obtained at high coated stent production levels.
  • An additional embodiment of the present method includes multiple direction reversals of endless belt 1 downstream of coating sprayer 10 such that stents 8 re-enter the spray dispensed from sprayer 10 several times before belt 1 returns to a stent removal station. By expanding the coating application step in this manner, this embodiment provides for enhanced coating efficiency as each pass of stents 8 through the downstream portions of the coating spray further improves the utilization of the sprayed coating and thereby improves coating efficiency.
  • A further advantage of the foregoing method is that after the step of applying the coating to the rolling stents, there may be provided additional steps which enhance high volume coated stent production. An exemplary further embodiment of the present method thus may include the step of passing the stents through a coating dryer (such as an infrared heater) following the application of the coating, wherein the rolling stents present all their coated surfaces to the dryer for even, accelerated drying prior to removal from their respective rotating pins 7. Alternatively, the conveyer and/or the stent holder may be heated to accelerate coating drying rates before the stents are removed from the conveyer.
  • In the foregoing first embodiment, the stents are placed on rotating pins with upper portions that are shaped to directly receive the stents. Alternatively, in the first step of the present high-volume coating method process, the stents may be supplied for loading onto endless belt 1 already mounted on individual stent holders, where the upper portion of rotating pins 7 is adapted to grasp one end of the holder. FIG. 6 shows three example stent holder and cooperating rotating pin arrangements which are amenable to high-volume automated stent placement and removal operations. In FIG. 6 a, stent 8 is mounted on stent holder 15. Stent holder 15 in turn is locked within a bayonet-type receiving portion 16 on top of rotating pin 7, where an extension 17 of stent holder 15 has been inserted into receiving portion 16 and rotated to lock the stent holder in place. Similarly, FIG. 6 b illustrates another stent holder 15 formed from a nitinol wire that holds stent 8 by spring force at contact points on the stent's inner surface, where receiving portion 16 is a spring-loaded clamp that grasps one end of stent holder 15. FIG. 6c shows a further exemplary embodiment, wherein stent holder 15 is a wire frame with triangular ends 18, stent 8 is held under a light compressive force between the ends 18, and extension 17 from stent holder 15 is a wire that is placed into the receiving portion 16 of rotating pin 7 (in this case, a hole drilled into the top of pin 7). FIG. 6 d shows another exemplary embodiment, wherein stent holder 15 is an inflatable balloon that lightly presses against the inner surface of stent 8 and is held, in this embodiment, in a receiving portion 16 that grasps one end of the stent holder balloon 15.
  • It should be understood that the foregoing description of various exemplary embodiments of possible stent holders and mating receiving mounts is not intended to be limiting, and a number of modifications and alternatives may be employed that would facilitate the performance of the present stent coating method at high production levels. Further, alternative coating and drying step arrangements may be employed, such as feeding the stents through multiple coating and drying cycles to apply a plurality of coats of coating material before the completed coated stent is removed from its stent holder, or conveying the stents through a plurality of coating sprayers spraying a plurality of different coatings, with or without drying periods between the coating layer applications.
  • The foregoing alternative approaches to the stent placement step, which positively constrain stents 8 to remain mounted on rotating pins 7, facilitate a further embodiment of the present method. In this embodiment, rather than performing the step of applying the stent coating by using a stent coating sprayer, the coating may be applied by advancing endless belt 1 through a stent coating bath 19, as schematically illustrated in FIG. 7. It should be apparent to those of skill in the art that while positive control of rolling stents 8 on the top of rotating pins 7 is not a necessary prerequisite to use of a coating bath, use of the foregoing alternative stent holders coupled to the rotating pins enhances the control of the stents as they pass through coating bath 19. It should be further noted that while endless belt 1 is shown in FIG. 7 as being turned to a horizontal position to pass through coating bath 19, no orientation limitations are intended to be implied by the foregoing description, as a number of modifications and equivalent alternative arrangements are possible. For example, endless belt 1 may be arranged above the coating bath and located such that stents 8 are held and rotated about their longitudinal axes below belt 1, such that only the stents and their holders pass through the coating bath during the coating application step.
  • The term “therapeutic agent” as used herein includes one or more “therapeutic agents” or “drugs.” The terms “therapeutic agents” and “drugs” are used interchangeably herein and include pharmaceutically active compounds, nucleic acids with and without carrier vectors such as lipids, compacting agents (such as histones), virus (such as adenovirus, andenoassociated virus, retrovirus, lentivirus and α-virus), polymers, hyaluronic acid, proteins, cells and the like, with or without targeting sequences.
  • Specific examples of therapeutic agents used in conjunction with the present invention include, for example, pharmaceutically active compounds, proteins, cells, oligonucleotides, ribozymes, anti-sense oligonucleotides, DNA compacting agents, gene/vector systems (i.e., any vehicle that allows for the uptake and expression of nucleic acids), nucleic acids (including, for example, recombinant nucleic acids; naked DNA, cDNA, RNA; genomic DNA, cDNA or RNA in a non-infectious vector or in a viral vector and which further may have attached peptide targeting sequences; antisense nucleic acid (RNA or DNA); and DNA chimeras which include gene sequences and encoding for ferry proteins such as membrane translocating sequences (“MTS”) and herpes simplex virus-1 (“VP22”)), and viral, liposomes and cationic and anionic polymers and neutral polymers that are selected from a number of types depending on the desired application. Non-limiting examples of virus vectors or vectors derived from viral sources include adenoviral vectors, herpes simplex vectors, papilloma vectors, adeno-associated vectors, retroviral vectors, and the like. Non-limiting examples of biologically active solutes include anti-thrombogenic agents such as heparin, heparin derivatives, urokinase, and PPACK (dextrophenylalanine proline arginine chloromethylketone); antioxidants such as probucol and retinoic acid; angiogenic and anti-angiogenic agents and factors; agents blocking smooth muscle cell proliferation such as rapamycin, angiopeptin, and monoclonal antibodies capable of blocking smooth muscle cell proliferation; anti-inflammatory agents such as dexamethasone, prednisolone, corticosterone, budesonide, estrogen, sulfasalazine, acetyl salicylic acid, and mesalamine; calcium entry blockers such as verapamil, diltiazem and nifedipine; antineoplastic/antiproliferative/anti-mitotic agents such as paclitaxel, 5-fluorouracil, methotrexate, doxorubicin, daunorubicin, cyclosporine, cisplatin, vinblastine, vincristine, epothilones, endostatin, angiostatin and thymidine kinase inhibitors; antimicrobials such as triclosan, cephalosporins, aminoglycosides, and nitorfurantoin; anesthetic agents such as lidocaine, bupivacaine, and ropivacaine; nitric oxide (NO) donors such as lisidomine, molsidomine, L-arginine, NO-protein adducts, NO-carbohydrate adducts, polymeric or oligomeric NO adducts; anti-coagulants such as D-Phe-Pro-Arg chloromethyl ketone, an RGD peptide-containing compound, heparin, antithrombin compounds, platelet receptor antagonists, anti-thrombin antibodies, anti-platelet receptor antibodies, enoxaparin, hirudin, Warafin sodium, Dicumarol, aspirin, prostaglandin inhibitors, platelet inhibitors and tick antiplatelet factors; vascular cell growth promotors such as growth factors, growth factor receptor antagonists, transcriptional activators, and translational promotors; vascular cell growth inhibitors such as growth factor inhibitors, growth factor receptor antagonists, transcriptional repressors, translational repressors, replication inhibitors, inhibitory antibodies, antibodies directed against growth factors, bifunctional molecules consisting of a growth factor and a cytotoxin, bifunctional molecules consisting of an antibody and a cytotoxin; cholesterol-lowering agents; vasodilating agents; agents which interfere with endogeneus vascoactive mechanisms; survival genes which protect against cell death, such as anti-apoptotic Bc1-2 family factors and Akt kinase; and combinations thereof. Cells can be of human origin (autologous or allogenic) or from an animal source (xenogeneic), genetically engineered if desired to deliver proteins of interest at the insertion site. Any modifications are routinely made by one skilled in the art.
  • Polynucleotide sequences useful in practice of the invention include DNA or RNA sequences having a therapeutic effect after being taken up by a cell. Examples of therapeutic polynucleotides include anti-sense DNA and RNA; DNA coding for an anti-sense RNA; or DNA coding for tRNA or rRNA to replace defective or deficient endogenous molecules or interfering RNA sequences. The polynucleotides can also code for therapeutic proteins or polypeptides. A polypeptide is understood to be any translation product of a polynucleotide regardless of size, and whether glycosylated or not. Therapeutic proteins and polypeptides include as a primary example, those proteins or polypeptides that can compensate for defective or deficient species in an animal, or those that act through toxic effects to limit or remove harmful cells from the body. In addition, the polypeptides or proteins that can be injected, or whose DNA can be incorporated, include without limitation, angiogenic factors and other molecules competent to induce angiogenesis, including acidic and basic fibroblast growth factors, vascular endothelial growth factor, hif-1, epidermal growth factor, transforming growth factor α and β, platelet-derived endothelial growth factor, platelet-derived growth factor, tumor necrosis factor α, hepatocyte growth factor and insulin like growth factor; growth factors; cell cycle inhibitors including CDK inhibitors; anti-restenosis agents, including p15, p16, p18, p19, p21, p27, p53, p57, Rb, nFkB and E2F decoys, thymidine kinase (“TK”) and combinations thereof and other agents useful for interfering with cell proliferation, including agents for treating malignancies; and combinations thereof. Still other useful factors, which can be provided as polypeptides or as DNA encoding these polypeptides, include monocyte chemoattractant protein (“MCP-1”), and the family of bone morphogenic proteins (“BMP's”). The known proteins include BMP-2, BMP-3, BMP-4, BMP-5, BMP-6 (Vgr-1), BMP-7 (OP-1), BMP-8, BMP-9, BMP-10, BMP-11, BMP-12, BMP-13, BMP-14, BMP-15, and BMP-16. Currently preferred BMP's are any of BMP-2, BMP-3, BMP-4, BMP-5, BMP-6 and BMP-7. These dimeric proteins can be provided as homodimers, heterodimers, or combinations thereof, alone or together with other molecules. Alternatively or, in addition, molecules capable of inducing an upstream or downstream effect of a BMP can be provided. Such molecules include any of the “hedgehog” proteins, or the DNA's encoding them.
  • While the present invention has been described with reference to what are presently considered to be preferred embodiments thereof, it is to be understood that the present invention is not limited to the disclosed embodiments or constructions. On the contrary, the present invention is intended to cover various modifications and equivalent arrangements. In addition, while the various elements of the disclosed invention are described and/or shown in various combinations and configurations, which are exemplary, other combinations and configurations, including more, less or only a single embodiment, are also within the spirit and scope of the present invention.

Claims (21)

1-21. (canceled)
22. A method for coating stents, comprising the steps of:
placing a plurality of stents on a plurality of stent holders, wherein the stent holders are attached to a conveyer;
turning the stent holders while the conveyer moves the stents; and
applying a coating to the turning stents as the stents pass through a coater.
23. The method of coating stents of claim 22, wherein the step of turning the stent holders while the conveyer moves the stents includes revolving the stent holders around a point.
24. The method of coating stents of claim 22, wherein the step of turning the stent holders while the conveyer moves the stents includes pivoting the stent holders.
25. The method of coating stents of claim 22, wherein the stent holders are removably attached to a conveyer.
26. The method of coating stents of claim 22, wherein the conveyer is an endless belt, and the endless belt is moving as the plurality of stents is placed on the plurality of stent holders.
27. The method of coating stents of claim 26, wherein the coater includes a coating sprayer, and the conveyer moves the plurality of stents through a coating spray released from the coating sprayer.
28. The method of coating stents of claim 26, wherein the coater includes a coating bath, and the conveyer moves the plurality of stents through the coating bath.
29. The method of coating stents of claim 27, wherein the step of applying a coating further comprises:
passing the stents through the coating spray at a first distance from the sprayer, then passing the stents through the coating spray at a second distance from the sprayer.
30. The method of coating stents of claim 26, wherein the step of placing a plurality of stents on a plurality of stent holders is performed with an automated stent loader.
31. The method of coating stents of claim 26, wherein the stent holders are revolving bases adapted to receive individual stent handling devices on which at least one stent is pre-mounted, and wherein the step of placing the stents on the stent holders further comprises:
placing stents pre-mounted on stent handling devices onto the stent holders by engaging the stent handling devices with the revolving bases.
32. The method of coating stents of claim 27, wherein the coating sprayer sprays the stent coating toward the stents from a plurality of directions.
33. The method of coating stents of claim 22, further comprising the step of:
drying the coated stents prior to removal of the coated stents from the stent holders.
34. A system for coating medical devices comprising:
a plurality of holders for holding a plurality of medical devices to be coated;
a conveyer;
a means for advancing the conveyer;
a means for turning the plurality of holders; and
a coater;
wherein the plurality of holders is attached to a conveyer, and wherein the means for turning the holder turns the plurality of holders and medical devices while the conveyer moves the medical devices through the coater, so that a coating is applied to the turning medical devices as the medical devices pass through the coater.
35. The system of claim 34, wherein at least one of the plurality of holders is adapted to receive each of the plurality of medical devices.
36. The system of claim 34, wherein the means for turning the plurality of holders is a backing plate.
37. The system of claim 36, wherein the plurality of holders is adapted to cooperate with the backing plate, so that the plurality of holders turns upon contact with the backing plate as the conveyer is advanced.
38. The system of claim 34, wherein the means for turning the plurality of holders is a gear mechanism.
39. The system of claim 34, further comprising a dryer.
40. The system of claim 34, wherein the medical devices are stents.
41. A system for coating stents comprising:
a plurality of stent holders for holding a plurality of stents to be coated;
a conveyer;
a means for advancing the conveyer;
a means for rotating the plurality of stent holders; and
a coater;
wherein the conveyer is an endless belt; and
wherein the plurality of stent holders is attached to the conveyer, and wherein the means for rotating the holder rotates the plurality of holders and stents while the conveyer moves the stents through the coater, so that a coating is applied to the rotating stents as the stents pass through the coater.
US11/073,848 2003-10-14 2005-03-08 Method for roll coating multiple stents Abandoned US20050158450A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/073,848 US20050158450A1 (en) 2003-10-14 2005-03-08 Method for roll coating multiple stents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/684,131 US6984411B2 (en) 2003-10-14 2003-10-14 Method for roll coating multiple stents
US11/073,848 US20050158450A1 (en) 2003-10-14 2005-03-08 Method for roll coating multiple stents

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/684,131 Continuation US6984411B2 (en) 2003-10-14 2003-10-14 Method for roll coating multiple stents

Publications (1)

Publication Number Publication Date
US20050158450A1 true US20050158450A1 (en) 2005-07-21

Family

ID=34422922

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/684,131 Expired - Lifetime US6984411B2 (en) 2003-10-14 2003-10-14 Method for roll coating multiple stents
US11/073,848 Abandoned US20050158450A1 (en) 2003-10-14 2005-03-08 Method for roll coating multiple stents

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/684,131 Expired - Lifetime US6984411B2 (en) 2003-10-14 2003-10-14 Method for roll coating multiple stents

Country Status (4)

Country Link
US (2) US6984411B2 (en)
EP (1) EP1682282B1 (en)
DE (1) DE602004016370D1 (en)
WO (1) WO2005037444A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050013870A1 (en) * 2003-07-17 2005-01-20 Toby Freyman Decellularized extracellular matrix of conditioned body tissues and uses thereof
US20070178137A1 (en) * 2006-02-01 2007-08-02 Toby Freyman Local control of inflammation
US20070193509A1 (en) * 2006-02-17 2007-08-23 Howmedica Osteonics Corp. Multi-station rotation system for use in spray operations
US20070259100A1 (en) * 2006-05-04 2007-11-08 Guerriero Ryan E Stent support devices
US20080124374A1 (en) * 2003-07-17 2008-05-29 Boston Scientific Scimed Decellularized bone marrow extracellular matrix
US20100109204A1 (en) * 2005-07-29 2010-05-06 Wu Patrick P Polymeric Stent Polishing Method And Apparatus
US20100266780A1 (en) * 2006-02-17 2010-10-21 Howmedica Osteonics Corp. Multi-station rotation system for use in spray operations
CN110694842A (en) * 2019-10-17 2020-01-17 陈明会 Turnover paint spraying device for freight car assembly line

Families Citing this family (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7959664B2 (en) 1996-12-26 2011-06-14 Medinol, Ltd. Flat process of drug coating for stents
US7807211B2 (en) 1999-09-03 2010-10-05 Advanced Cardiovascular Systems, Inc. Thermal treatment of an implantable medical device
US20070032853A1 (en) 2002-03-27 2007-02-08 Hossainy Syed F 40-O-(2-hydroxy)ethyl-rapamycin coated stent
US6953560B1 (en) 2000-09-28 2005-10-11 Advanced Cardiovascular Systems, Inc. Barriers for polymer-coated implantable medical devices and methods for making the same
US20040073294A1 (en) 2002-09-20 2004-04-15 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
US7862495B2 (en) 2001-05-31 2011-01-04 Advanced Cardiovascular Systems, Inc. Radiation or drug delivery source with activity gradient to minimize edge effects
US6656216B1 (en) * 2001-06-29 2003-12-02 Advanced Cardiovascular Systems, Inc. Composite stent with regioselective material
US7758636B2 (en) 2002-09-20 2010-07-20 Innovational Holdings Llc Expandable medical device with openings for delivery of multiple beneficial agents
US7192484B2 (en) * 2002-09-27 2007-03-20 Surmodics, Inc. Advanced coating apparatus and method
US8435550B2 (en) 2002-12-16 2013-05-07 Abbot Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US7758881B2 (en) 2004-06-30 2010-07-20 Advanced Cardiovascular Systems, Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US20060002968A1 (en) 2004-06-30 2006-01-05 Gordon Stewart Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders
US8281737B2 (en) * 2003-03-10 2012-10-09 Boston Scientific Scimed, Inc. Coated medical device and method for manufacturing the same
EP1610823B1 (en) 2003-03-28 2011-09-28 Innovational Holdings, LLC Implantable medical device with continuous agent concentration gradient
US20050118344A1 (en) 2003-12-01 2005-06-02 Pacetti Stephen D. Temperature controlled crimping
US7785653B2 (en) 2003-09-22 2010-08-31 Innovational Holdings Llc Method and apparatus for loading a beneficial agent into an expandable medical device
US20050147734A1 (en) * 2004-01-07 2005-07-07 Jan Seppala Method and system for coating tubular medical devices
US20050196518A1 (en) * 2004-03-03 2005-09-08 Stenzel Eric B. Method and system for making a coated medical device
US8709469B2 (en) 2004-06-30 2014-04-29 Abbott Cardiovascular Systems Inc. Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
US7648727B2 (en) 2004-08-26 2010-01-19 Advanced Cardiovascular Systems, Inc. Methods for manufacturing a coated stent-balloon assembly
US7795467B1 (en) 2005-04-26 2010-09-14 Advanced Cardiovascular Systems, Inc. Bioabsorbable, biobeneficial polyurethanes for use in medical devices
US8778375B2 (en) 2005-04-29 2014-07-15 Advanced Cardiovascular Systems, Inc. Amorphous poly(D,L-lactide) coating
US8021676B2 (en) 2005-07-08 2011-09-20 Advanced Cardiovascular Systems, Inc. Functionalized chemically inert polymers for coatings
US20090062909A1 (en) * 2005-07-15 2009-03-05 Micell Technologies, Inc. Stent with polymer coating containing amorphous rapamycin
AU2006270221B2 (en) 2005-07-15 2012-01-19 Micell Technologies, Inc. Polymer coatings containing drug powder of controlled morphology
US7785647B2 (en) 2005-07-25 2010-08-31 Advanced Cardiovascular Systems, Inc. Methods of providing antioxidants to a drug containing product
US7976891B1 (en) 2005-12-16 2011-07-12 Advanced Cardiovascular Systems, Inc. Abluminal stent coating apparatus and method of using focused acoustic energy
US7867547B2 (en) 2005-12-19 2011-01-11 Advanced Cardiovascular Systems, Inc. Selectively coating luminal surfaces of stents
US20070196428A1 (en) 2006-02-17 2007-08-23 Thierry Glauser Nitric oxide generating medical devices
US7713637B2 (en) 2006-03-03 2010-05-11 Advanced Cardiovascular Systems, Inc. Coating containing PEGylated hyaluronic acid and a PEGylated non-hyaluronic acid polymer
ES2540059T3 (en) 2006-04-26 2015-07-08 Micell Technologies, Inc. Coatings containing multiple drugs
US20070259116A1 (en) * 2006-05-02 2007-11-08 Boston Scientific Scimed, Inc. Partially coated workpiece and method of making same
US20070259114A1 (en) * 2006-05-02 2007-11-08 Boston Scientific Scimed, Inc. Partially coated workpieces and method and system for making the same
US7727598B2 (en) * 2006-05-02 2010-06-01 Boston Scientific Scimed, Inc. Partially roll coated workpiece and methods and systems for making the same
US7985441B1 (en) 2006-05-04 2011-07-26 Yiwen Tang Purification of polymers for coating applications
US8304012B2 (en) 2006-05-04 2012-11-06 Advanced Cardiovascular Systems, Inc. Method for drying a stent
US7775178B2 (en) * 2006-05-26 2010-08-17 Advanced Cardiovascular Systems, Inc. Stent coating apparatus and method
US9561351B2 (en) 2006-05-31 2017-02-07 Advanced Cardiovascular Systems, Inc. Drug delivery spiral coil construct
US8568764B2 (en) 2006-05-31 2013-10-29 Advanced Cardiovascular Systems, Inc. Methods of forming coating layers for medical devices utilizing flash vaporization
US8703167B2 (en) 2006-06-05 2014-04-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical devices for controlled release of a hydrophilic drug and a hydrophobic drug
US8097291B2 (en) * 2006-06-05 2012-01-17 Boston Scientific Scimed, Inc. Methods for coating workpieces
US20070281072A1 (en) * 2006-06-06 2007-12-06 Boston Scientific Scimed, Inc. Coating a workpiece using a metering device and workpieces coated with this metering device
US8778376B2 (en) 2006-06-09 2014-07-15 Advanced Cardiovascular Systems, Inc. Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating
US8603530B2 (en) 2006-06-14 2013-12-10 Abbott Cardiovascular Systems Inc. Nanoshell therapy
US8114150B2 (en) 2006-06-14 2012-02-14 Advanced Cardiovascular Systems, Inc. RGD peptide attached to bioabsorbable stents
US8048448B2 (en) 2006-06-15 2011-11-01 Abbott Cardiovascular Systems Inc. Nanoshells for drug delivery
US8017237B2 (en) 2006-06-23 2011-09-13 Abbott Cardiovascular Systems, Inc. Nanoshells on polymers
US9028859B2 (en) 2006-07-07 2015-05-12 Advanced Cardiovascular Systems, Inc. Phase-separated block copolymer coatings for implantable medical devices
US8703169B1 (en) 2006-08-15 2014-04-22 Abbott Cardiovascular Systems Inc. Implantable device having a coating comprising carrageenan and a biostable polymer
US8636767B2 (en) 2006-10-02 2014-01-28 Micell Technologies, Inc. Surgical sutures having increased strength
US8011316B2 (en) 2006-10-18 2011-09-06 Innovational Holdings, Llc Systems and methods for producing a medical device
WO2008051339A1 (en) * 2006-10-20 2008-05-02 Boston Scientific Limited Film coating medical devices
US9539593B2 (en) 2006-10-23 2017-01-10 Micell Technologies, Inc. Holder for electrically charging a substrate during coating
US8597673B2 (en) 2006-12-13 2013-12-03 Advanced Cardiovascular Systems, Inc. Coating of fast absorption or dissolution
US8114466B2 (en) * 2007-01-03 2012-02-14 Boston Scientific Scimed, Inc. Methods of applying coating to the inside surface of a stent
US9737642B2 (en) 2007-01-08 2017-08-22 Micell Technologies, Inc. Stents having biodegradable layers
US11426494B2 (en) 2007-01-08 2022-08-30 MT Acquisition Holdings LLC Stents having biodegradable layers
US8119151B2 (en) * 2007-04-20 2012-02-21 Boston Scientific Scimed, Inc. Spread coating a medical device
US8147769B1 (en) 2007-05-16 2012-04-03 Abbott Cardiovascular Systems Inc. Stent and delivery system with reduced chemical degradation
AU2008256684B2 (en) * 2007-05-25 2012-06-14 Micell Technologies, Inc. Polymer films for medical device coating
US9056155B1 (en) 2007-05-29 2015-06-16 Abbott Cardiovascular Systems Inc. Coatings having an elastic primer layer
US8109904B1 (en) 2007-06-25 2012-02-07 Abbott Cardiovascular Systems Inc. Drug delivery medical devices
US8048441B2 (en) 2007-06-25 2011-11-01 Abbott Cardiovascular Systems, Inc. Nanobead releasing medical devices
US20090041845A1 (en) * 2007-08-08 2009-02-12 Lothar Walter Kleiner Implantable medical devices having thin absorbable coatings
CA2721832C (en) * 2008-04-17 2018-08-07 Micell Technologies, Inc. Stents having bioabsorbable layers
JP2011528275A (en) 2008-07-17 2011-11-17 ミセル テクノロジーズ,インク. Drug delivery medical device
US9510856B2 (en) 2008-07-17 2016-12-06 Micell Technologies, Inc. Drug delivery medical device
US8834913B2 (en) 2008-12-26 2014-09-16 Battelle Memorial Institute Medical implants and methods of making medical implants
CA2756307C (en) * 2009-03-23 2017-08-08 Micell Technologies, Inc. Peripheral stents having layers and reinforcement fibers
EP2411440B1 (en) * 2009-03-23 2018-01-17 Micell Technologies, Inc. Improved biodegradable polymers
US20100239635A1 (en) * 2009-03-23 2010-09-23 Micell Technologies, Inc. Drug delivery medical device
CN102481195B (en) * 2009-04-01 2015-03-25 米歇尔技术公司 Drug delivery medical device
EP3366326A1 (en) 2009-04-17 2018-08-29 Micell Technologies, Inc. Stents having controlled elution
JP2012533431A (en) 2009-07-20 2012-12-27 ボストン サイエンティフィック サイムド,インコーポレイテッド Medical device coating system
US8573148B2 (en) 2009-09-04 2013-11-05 Abbott Cardiovascular Systems Inc. System for coating a stent
US8241018B2 (en) * 2009-09-10 2012-08-14 Tyco Healthcare Group Lp Compact peristaltic medical pump
WO2011097103A1 (en) 2010-02-02 2011-08-11 Micell Technologies, Inc. Stent and stent delivery system with improved deliverability
US8795762B2 (en) * 2010-03-26 2014-08-05 Battelle Memorial Institute System and method for enhanced electrostatic deposition and surface coatings
WO2011133655A1 (en) 2010-04-22 2011-10-27 Micell Technologies, Inc. Stents and other devices having extracellular matrix coating
CA2805631C (en) 2010-07-16 2018-07-31 Micell Technologies, Inc. Drug delivery medical device
WO2012166819A1 (en) 2011-05-31 2012-12-06 Micell Technologies, Inc. System and process for formation of a time-released, drug-eluting transferable coating
US10117972B2 (en) 2011-07-15 2018-11-06 Micell Technologies, Inc. Drug delivery medical device
US10188772B2 (en) 2011-10-18 2019-01-29 Micell Technologies, Inc. Drug delivery medical device
US9204982B2 (en) * 2012-04-26 2015-12-08 Medtronic Vascular, Inc. Apparatus and methods for filling a drug eluting medical device via capillary action
US9597205B2 (en) 2012-06-06 2017-03-21 Magenta Medical Ltd. Prosthetic renal valve
AU2014248508B2 (en) 2013-03-12 2018-11-08 Micell Technologies, Inc. Bioabsorbable biomedical implants
AU2014229150B2 (en) 2013-03-13 2018-02-22 Magenta Medical Ltd. Renal pump
US10583231B2 (en) 2013-03-13 2020-03-10 Magenta Medical Ltd. Blood pump
JP2016519965A (en) 2013-05-15 2016-07-11 マイセル・テクノロジーズ,インコーポレイテッド Bioabsorbable biomedical implant
US9764113B2 (en) 2013-12-11 2017-09-19 Magenta Medical Ltd Curved catheter
US9459193B2 (en) * 2013-12-18 2016-10-04 Abbott Cardiovascular Systems Inc. Stent holder having a reduced profile
US20150219405A1 (en) * 2014-02-05 2015-08-06 Lennox Industries Inc. Cladded brazed alloy tube for system components
US11291824B2 (en) 2015-05-18 2022-04-05 Magenta Medical Ltd. Blood pump
EP3468511B1 (en) 2016-06-10 2020-04-15 Medtronic Vascular Inc. Customizing the elution profile of a stent
CN106179838B (en) * 2016-08-18 2019-01-18 珠海同振防腐工程有限公司 Rotary type tower coating machine
WO2018061002A1 (en) 2016-09-29 2018-04-05 Magenta Medical Ltd. Blood vessel tube
EP3532120A1 (en) 2016-10-25 2019-09-04 Magenta Medical Ltd. Ventricular assist device
JP7094279B2 (en) 2016-11-23 2022-07-01 マジェンタ・メディカル・リミテッド Blood pump
US10226367B2 (en) 2016-12-19 2019-03-12 Medtronic Vascular, Inc. Apparatus and methods for filling a drug eluting medical device via capillary action
DE102017130653A1 (en) * 2017-12-20 2019-06-27 Schaeffler Technologies AG & Co. KG Conveyor and inline coating system with such a conveyor
US10905808B2 (en) 2018-01-10 2021-02-02 Magenta Medical Ltd. Drive cable for use with a blood pump
CN115192897A (en) 2018-01-10 2022-10-18 马真塔医药有限公司 Ventricular assist device
US10893927B2 (en) 2018-03-29 2021-01-19 Magenta Medical Ltd. Inferior vena cava blood-flow implant
EP3660184A1 (en) * 2018-11-30 2020-06-03 Biotronik Ag Holders for complete pecvd-coating of bodies, in particular stents
CN109550626A (en) * 2019-01-03 2019-04-02 广东省新材料研究所 A kind of spray process platform and spraying process control system
AU2020211431A1 (en) 2019-01-24 2021-07-15 Magenta Medical Ltd Ventricular assist device
CN111097643A (en) * 2020-02-14 2020-05-05 淳安县立亿杯业有限公司 Circulating automatic paint spraying machine for vacuum cup
CN112007803B (en) * 2020-08-25 2021-12-17 绍兴市上虞欣隆防腐设备有限公司 Fluorine spraying mechanism for multi-station corrosion-resistant equipment processing
CN114192318B (en) * 2021-12-28 2023-06-06 东莞市锐森灯饰有限公司 Lamp shade surface spraying equipment
CN114425492B (en) * 2022-02-17 2023-01-20 江苏正永地面装饰材料有限公司 Production system of processing of PVC panel

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2334087A (en) * 1938-10-17 1943-11-09 Crown Cork & Seal Co Coating apparatus
US3310027A (en) * 1964-04-20 1967-03-21 Hooker Chemical Corp Liquid coating apparatus
US5534287A (en) * 1993-04-23 1996-07-09 Schneider (Europe) A.G. Methods for applying an elastic coating layer on stents
US5620738A (en) * 1995-06-07 1997-04-15 Union Carbide Chemicals & Plastics Technology Corporation Non-reactive lubicious coating process
US6284305B1 (en) * 1996-06-13 2001-09-04 Schneider (Usa) Inc. Drug coating with topcoat
US20020023585A1 (en) * 2000-08-31 2002-02-28 Kouichi Sashihara Painting equipment and painting method
US20020127327A1 (en) * 1999-04-19 2002-09-12 Schwarz Marlene C. Mechanical and acoustical suspension coating of medical implants
US6554942B2 (en) * 2000-12-28 2003-04-29 Scimed Life Systems, Inc. Method of manufacturing a guidewire with an extrusion jacket
US6562136B1 (en) * 2000-09-08 2003-05-13 Surmodics, Inc. Coating apparatus and method
US20040047994A1 (en) * 2002-09-09 2004-03-11 Robert Becker Method and apparatus for the removal of excess coating material from a honeycomb body
US6743462B1 (en) * 2001-05-31 2004-06-01 Advanced Cardiovascular Systems, Inc. Apparatus and method for coating implantable devices

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL82716C (en) * 1951-05-31
US4009301A (en) * 1974-09-05 1977-02-22 Owens-Illinois, Inc. Method for powder coating
JPH0549984A (en) * 1991-08-27 1993-03-02 Mitsubishi Electric Corp Cylindrical spray coat rotating device
DE19701193C1 (en) * 1997-01-15 1998-06-10 Stahlschmidt & Maiworm Device for coating of wheels of motor vehicles
US7105198B2 (en) * 2002-01-14 2006-09-12 Medtronic Vascular, Inc. Method for coating stent

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2334087A (en) * 1938-10-17 1943-11-09 Crown Cork & Seal Co Coating apparatus
US3310027A (en) * 1964-04-20 1967-03-21 Hooker Chemical Corp Liquid coating apparatus
US5534287A (en) * 1993-04-23 1996-07-09 Schneider (Europe) A.G. Methods for applying an elastic coating layer on stents
US5620738A (en) * 1995-06-07 1997-04-15 Union Carbide Chemicals & Plastics Technology Corporation Non-reactive lubicious coating process
US6284305B1 (en) * 1996-06-13 2001-09-04 Schneider (Usa) Inc. Drug coating with topcoat
US20020127327A1 (en) * 1999-04-19 2002-09-12 Schwarz Marlene C. Mechanical and acoustical suspension coating of medical implants
US6730349B2 (en) * 1999-04-19 2004-05-04 Scimed Life Systems, Inc. Mechanical and acoustical suspension coating of medical implants
US20020023585A1 (en) * 2000-08-31 2002-02-28 Kouichi Sashihara Painting equipment and painting method
US6562136B1 (en) * 2000-09-08 2003-05-13 Surmodics, Inc. Coating apparatus and method
US6554942B2 (en) * 2000-12-28 2003-04-29 Scimed Life Systems, Inc. Method of manufacturing a guidewire with an extrusion jacket
US6743462B1 (en) * 2001-05-31 2004-06-01 Advanced Cardiovascular Systems, Inc. Apparatus and method for coating implantable devices
US20040047994A1 (en) * 2002-09-09 2004-03-11 Robert Becker Method and apparatus for the removal of excess coating material from a honeycomb body

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080124374A1 (en) * 2003-07-17 2008-05-29 Boston Scientific Scimed Decellularized bone marrow extracellular matrix
US8790920B2 (en) 2003-07-17 2014-07-29 Boston Scientific Scimed, Inc. Decellularized bone marrow extracellular matrix
US20050013870A1 (en) * 2003-07-17 2005-01-20 Toby Freyman Decellularized extracellular matrix of conditioned body tissues and uses thereof
US20090138074A1 (en) * 2003-07-17 2009-05-28 Boston Scientific Scimed, Inc. Decellularized extracellular matrix of conditioned body tissues and uses thereof
US8580180B2 (en) * 2005-07-29 2013-11-12 Advanced Cardiovascular Systems, Inc. Polymeric stent polishing method and apparatus
US20100109204A1 (en) * 2005-07-29 2010-05-06 Wu Patrick P Polymeric Stent Polishing Method And Apparatus
US20140167324A1 (en) * 2005-07-29 2014-06-19 Abbott Cardiovascular Systems Inc. Polymeric stent polishing method and apparatus
US20100092448A1 (en) * 2006-02-01 2010-04-15 Boston Scientific Scimed, Inc. Local control of inflammation
US20070178137A1 (en) * 2006-02-01 2007-08-02 Toby Freyman Local control of inflammation
US20100266780A1 (en) * 2006-02-17 2010-10-21 Howmedica Osteonics Corp. Multi-station rotation system for use in spray operations
US7836847B2 (en) 2006-02-17 2010-11-23 Howmedica Osteonics Corp. Multi-station rotation system for use in spray operations
US7981479B2 (en) 2006-02-17 2011-07-19 Howmedica Osteonics Corp. Multi-station rotation system for use in spray operations
US20070193509A1 (en) * 2006-02-17 2007-08-23 Howmedica Osteonics Corp. Multi-station rotation system for use in spray operations
US20070259100A1 (en) * 2006-05-04 2007-11-08 Guerriero Ryan E Stent support devices
US8069814B2 (en) * 2006-05-04 2011-12-06 Advanced Cardiovascular Systems, Inc. Stent support devices
CN110694842A (en) * 2019-10-17 2020-01-17 陈明会 Turnover paint spraying device for freight car assembly line

Also Published As

Publication number Publication date
US6984411B2 (en) 2006-01-10
EP1682282B1 (en) 2008-09-03
EP1682282A1 (en) 2006-07-26
US20050079274A1 (en) 2005-04-14
DE602004016370D1 (en) 2008-10-16
WO2005037444A1 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
US6984411B2 (en) Method for roll coating multiple stents
EP1723938B1 (en) Stent coating holder
US9272307B2 (en) Contact coating of prostheses
EP1480760B1 (en) Mechanical and acoustical suspension coating of medical implants
US7060319B2 (en) method for using an ultrasonic nozzle to coat a medical appliance
US8173200B2 (en) Selective application of therapeutic agent to a medical device
US20060122698A1 (en) Treated medical implant
US7335264B2 (en) Differentially coated medical devices, system for differentially coating medical devices, and coating method
US6676987B2 (en) Coating a medical appliance with a bubble jet printing head
US20090123517A1 (en) Medical devices for releasing therapeutic agent and methods of making the same
US20050147734A1 (en) Method and system for coating tubular medical devices
EP1682307A1 (en) Method and apparatus for selective ablation of coatings from medical devices
US20050058768A1 (en) Method for coating prosthetic stents
US20070259116A1 (en) Partially coated workpiece and method of making same
US8147899B2 (en) Methods and systems for depositing coating on a medical device
US20030165614A1 (en) Coating a medical implant using a pan coater

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION